Regor Therapeutics Funding: $90M Raised, Series B (2021)

Regor Therapeutics funding overview

Regor Therapeutics is based in Shanghai, China. Regor Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for Regor Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Loyal Valley Capital, Lanting Capital, TF Capital, Vertex Ventures China, Qilu Pharmaceutical Group. 6 distinct backers are named across the disclosed rounds.

Regor Therapeutics at a glance

Total raised: $90M
Latest round: Series B
Latest round date: February 2021
Headquarters: Shanghai, China
Notable investors: Lilly Asia Ventures, Loyal Valley Capital, Lanting Capital, TF Capital, Vertex Ventures China, Qilu Pharmaceutical Group

Frequently asked about Regor Therapeutics funding

How much has Regor Therapeutics raised?: Regor Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Regor Therapeutics?: Lilly Asia Ventures, Loyal Valley Capital, Lanting Capital, TF Capital, Vertex Ventures China, Qilu Pharmaceutical Group are named among the investors backing Regor Therapeutics.
What was the latest Regor Therapeutics funding round?: The most recent disclosed round is a Series B, announced in February 2021.
Where is Regor Therapeutics based?: Regor Therapeutics is based in Shanghai, China.
When did Regor Therapeutics last raise?: The last disclosed Regor Therapeutics round closed in February 2021 at Series B.

Totals shown for Regor Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.

Regor Therapeutics Funding: $90M Raised, Series B (2021)

Regor Therapeutics funding overview

Regor Therapeutics at a glance

Frequently asked about Regor Therapeutics funding

Companies related to Regor Therapeutics (36)

Browse related funding lists (8)